Pillar Invest Corp - Jul 12, 2023 Form 4 Insider Report for Aceragen, Inc. (ACGN)

Role
10%+ Owner
Signature
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
Stock symbol
ACGN
Transactions as of
Jul 12, 2023
Transactions value $
-$9,104
Form type
4
Date filed
7/19/2023, 04:05 PM
Previous filing
Jul 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACGN Common Stock Sale -$5.7K -3.61K -2.11% $1.58 167K Jul 12, 2023 By Abude Umari See Footnote F1
transaction ACGN Common Stock Sale -$3.41K -2.21K -1.32% $1.54 165K Jul 13, 2023 By Abude Umari See Footnote F1
holding ACGN Common Stock 355K Jul 12, 2023 By Pillar Partners Foundation, L.P. See Footnote F1
holding ACGN Common Stock 136K Jul 12, 2023 By Pillar Pharmaceuticals 6, L.P. See Footnote F1
holding ACGN Common Stock 1.55K Jul 12, 2023 By Youssef El Zein See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.

Remarks:

Mr. Umari's 29,965 shares of the Issuer's Common Stock purchased on May 17, 2023 are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with Mr. Umari's sales of 3,605 shares of the Issuer's Common Stock on July 12, 2023 and of 2,213 shares of the Issuer's Common Stock on July 13, 2023. Mr. Umari has made arrangements with the Issuer to voluntarily disgorge $842.36 to the Issuer, which represents the full amount of Mr. Umari's short-swing profit realized from the matchable transactions as calculated pursuant to Section 16(b).